JP7143079B2 - 最適化された固体基材、それとともに使用するためのツールならびに細胞及び組織の成長を促進するためのその使用 - Google Patents
最適化された固体基材、それとともに使用するためのツールならびに細胞及び組織の成長を促進するためのその使用 Download PDFInfo
- Publication number
- JP7143079B2 JP7143079B2 JP2017554568A JP2017554568A JP7143079B2 JP 7143079 B2 JP7143079 B2 JP 7143079B2 JP 2017554568 A JP2017554568 A JP 2017554568A JP 2017554568 A JP2017554568 A JP 2017554568A JP 7143079 B2 JP7143079 B2 JP 7143079B2
- Authority
- JP
- Japan
- Prior art keywords
- solid substrate
- tissue
- solid
- implantation
- substrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000758 substrate Substances 0.000 title claims description 479
- 239000007787 solid Substances 0.000 title claims description 437
- 230000008467 tissue growth Effects 0.000 title claims description 39
- 230000010261 cell growth Effects 0.000 title claims description 35
- 230000001737 promoting effect Effects 0.000 title claims description 30
- 239000012530 fluid Substances 0.000 claims description 172
- 238000002513 implantation Methods 0.000 claims description 165
- 238000000034 method Methods 0.000 claims description 124
- 238000010521 absorption reaction Methods 0.000 claims description 119
- 235000014653 Carica parviflora Nutrition 0.000 claims description 107
- 241000243321 Cnidaria Species 0.000 claims description 90
- -1 silk Polymers 0.000 claims description 53
- 150000001875 compounds Chemical class 0.000 claims description 45
- 230000002269 spontaneous effect Effects 0.000 claims description 26
- 241000204400 Goniopora Species 0.000 claims description 22
- 229920000249 biocompatible polymer Polymers 0.000 claims description 22
- 239000011148 porous material Substances 0.000 claims description 18
- 230000001225 therapeutic effect Effects 0.000 claims description 18
- 241000242733 Acropora Species 0.000 claims description 16
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 13
- 229920002674 hyaluronan Polymers 0.000 claims description 13
- 229960003160 hyaluronic acid Drugs 0.000 claims description 13
- 239000003102 growth factor Substances 0.000 claims description 10
- 229920001661 Chitosan Polymers 0.000 claims description 8
- 229920005615 natural polymer Polymers 0.000 claims description 8
- 235000010443 alginic acid Nutrition 0.000 claims description 7
- 229920000615 alginic acid Polymers 0.000 claims description 7
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 6
- 102000004127 Cytokines Human genes 0.000 claims description 6
- 108090000695 Cytokines Proteins 0.000 claims description 6
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 6
- 241000498654 Millepora Species 0.000 claims description 6
- 229940072056 alginate Drugs 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- 241000204357 Porites Species 0.000 claims description 4
- 235000010410 calcium alginate Nutrition 0.000 claims description 4
- 239000000648 calcium alginate Substances 0.000 claims description 4
- 229960002681 calcium alginate Drugs 0.000 claims description 4
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 3
- 102000016942 Elastin Human genes 0.000 claims description 2
- 108010014258 Elastin Proteins 0.000 claims description 2
- 102000009123 Fibrin Human genes 0.000 claims description 2
- 108010073385 Fibrin Proteins 0.000 claims description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 2
- 229920002549 elastin Polymers 0.000 claims description 2
- 229950003499 fibrin Drugs 0.000 claims description 2
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 description 235
- 239000007943 implant Substances 0.000 description 116
- 210000000988 bone and bone Anatomy 0.000 description 100
- 210000004027 cell Anatomy 0.000 description 96
- 229920000642 polymer Polymers 0.000 description 80
- 210000000845 cartilage Anatomy 0.000 description 75
- 238000003780 insertion Methods 0.000 description 73
- 230000008439 repair process Effects 0.000 description 73
- 230000037431 insertion Effects 0.000 description 72
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 69
- 238000007493 shaping process Methods 0.000 description 64
- 230000007547 defect Effects 0.000 description 63
- 230000001681 protective effect Effects 0.000 description 54
- 230000006870 function Effects 0.000 description 50
- 238000000605 extraction Methods 0.000 description 46
- 239000000463 material Substances 0.000 description 39
- 230000000295 complement effect Effects 0.000 description 28
- 238000000576 coating method Methods 0.000 description 27
- 210000000130 stem cell Anatomy 0.000 description 27
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 24
- 239000011780 sodium chloride Substances 0.000 description 23
- 239000011248 coating agent Substances 0.000 description 22
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 20
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 19
- 239000008103 glucose Substances 0.000 description 19
- 241000242757 Anthozoa Species 0.000 description 17
- 206010017076 Fracture Diseases 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 238000002360 preparation method Methods 0.000 description 15
- 239000011343 solid material Substances 0.000 description 15
- 238000005553 drilling Methods 0.000 description 14
- 239000012636 effector Substances 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 239000004971 Cross linker Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 239000011800 void material Substances 0.000 description 12
- 239000013060 biological fluid Substances 0.000 description 11
- 208000014674 injury Diseases 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 238000001356 surgical procedure Methods 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 208000035475 disorder Diseases 0.000 description 10
- 238000010348 incorporation Methods 0.000 description 10
- 230000013011 mating Effects 0.000 description 10
- 201000009859 Osteochondrosis Diseases 0.000 description 9
- 230000006378 damage Effects 0.000 description 9
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 9
- 230000000399 orthopedic effect Effects 0.000 description 9
- 201000008482 osteoarthritis Diseases 0.000 description 9
- 230000017423 tissue regeneration Effects 0.000 description 9
- 210000001503 joint Anatomy 0.000 description 8
- 230000007246 mechanism Effects 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 239000013598 vector Substances 0.000 description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical group [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000002738 chelating agent Substances 0.000 description 7
- 230000001976 improved effect Effects 0.000 description 7
- 238000011065 in-situ storage Methods 0.000 description 7
- 238000011069 regeneration method Methods 0.000 description 7
- 230000008733 trauma Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 6
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 238000004873 anchoring Methods 0.000 description 6
- 229940112869 bone morphogenetic protein Drugs 0.000 description 6
- 230000022159 cartilage development Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 210000001612 chondrocyte Anatomy 0.000 description 6
- 239000003431 cross linking reagent Substances 0.000 description 6
- 238000005520 cutting process Methods 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 230000006641 stabilisation Effects 0.000 description 6
- 238000011105 stabilization Methods 0.000 description 6
- 229910021532 Calcite Inorganic materials 0.000 description 5
- 206010031264 Osteonecrosis Diseases 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 230000011164 ossification Effects 0.000 description 5
- 230000008929 regeneration Effects 0.000 description 5
- 230000000087 stabilizing effect Effects 0.000 description 5
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- 208000010392 Bone Fractures Diseases 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000000735 allogeneic effect Effects 0.000 description 4
- 210000003423 ankle Anatomy 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 210000001188 articular cartilage Anatomy 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 230000010072 bone remodeling Effects 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 210000001671 embryonic stem cell Anatomy 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 210000001624 hip Anatomy 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000000963 osteoblast Anatomy 0.000 description 4
- 210000004409 osteocyte Anatomy 0.000 description 4
- 210000005259 peripheral blood Anatomy 0.000 description 4
- 239000011886 peripheral blood Substances 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 description 4
- 210000002536 stromal cell Anatomy 0.000 description 4
- 210000002437 synoviocyte Anatomy 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 206010051763 Bone marrow oedema Diseases 0.000 description 3
- 108091006146 Channels Proteins 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 3
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 3
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 229920002732 Polyanhydride Polymers 0.000 description 3
- 229920000954 Polyglycolide Polymers 0.000 description 3
- 229920001710 Polyorthoester Polymers 0.000 description 3
- 102000013275 Somatomedins Human genes 0.000 description 3
- 108010009583 Transforming Growth Factors Proteins 0.000 description 3
- 102000009618 Transforming Growth Factors Human genes 0.000 description 3
- 210000001789 adipocyte Anatomy 0.000 description 3
- 238000006065 biodegradation reaction Methods 0.000 description 3
- 230000010478 bone regeneration Effects 0.000 description 3
- 239000000316 bone substitute Substances 0.000 description 3
- 208000015100 cartilage disease Diseases 0.000 description 3
- 238000002591 computed tomography Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 229940126864 fibroblast growth factor Drugs 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 210000004394 hip joint Anatomy 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002595 magnetic resonance imaging Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 210000002997 osteoclast Anatomy 0.000 description 3
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 210000002832 shoulder Anatomy 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012876 topography Methods 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 241001464437 Astreopora Species 0.000 description 2
- 208000030016 Avascular necrosis Diseases 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- 208000020084 Bone disease Diseases 0.000 description 2
- 206010061762 Chondropathy Diseases 0.000 description 2
- 208000005243 Chondrosarcoma Diseases 0.000 description 2
- 241000204487 Coscinaraea Species 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 241000333074 Eucalyptus occidentalis Species 0.000 description 2
- 241000204348 Fungia Species 0.000 description 2
- 102000006395 Globulins Human genes 0.000 description 2
- 108010044091 Globulins Proteins 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 2
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 208000032984 Intraoperative Complications Diseases 0.000 description 2
- 206010061223 Ligament injury Diseases 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 241000131492 Millepora dichotoma Species 0.000 description 2
- 108010025020 Nerve Growth Factor Proteins 0.000 description 2
- 102000015336 Nerve Growth Factor Human genes 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 208000002565 Open Fractures Diseases 0.000 description 2
- 206010073853 Osteochondral fracture Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
- 229920001244 Poly(D,L-lactide) Polymers 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 241000498156 Porites lutea Species 0.000 description 2
- 206010057765 Procedural complication Diseases 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- 229920001963 Synthetic biodegradable polymer Polymers 0.000 description 2
- 229920002494 Zein Polymers 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 210000002798 bone marrow cell Anatomy 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 229940045110 chitosan Drugs 0.000 description 2
- 229940097362 cyclodextrins Drugs 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000003412 degenerative effect Effects 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 238000000326 densiometry Methods 0.000 description 2
- 210000001513 elbow Anatomy 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 210000002758 humerus Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 210000000066 myeloid cell Anatomy 0.000 description 2
- 239000006225 natural substrate Substances 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 229940053128 nerve growth factor Drugs 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 208000005368 osteomalacia Diseases 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 230000001023 pro-angiogenic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000005019 zein Substances 0.000 description 2
- 229940093612 zein Drugs 0.000 description 2
- JWDFQMWEFLOOED-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(pyridin-2-yldisulfanyl)propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCSSC1=CC=CC=N1 JWDFQMWEFLOOED-UHFFFAOYSA-N 0.000 description 1
- FXYPGCIGRDZWNR-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-[[3-(2,5-dioxopyrrolidin-1-yl)oxy-3-oxopropyl]disulfanyl]propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCSSCCC(=O)ON1C(=O)CCC1=O FXYPGCIGRDZWNR-UHFFFAOYSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- LIFNDDBLJFPEAN-BPSSIEEOSA-N (2s)-4-amino-2-[[(2s)-2-[[2-[[2-[[(2s)-5-amino-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]amino]hexanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H]1CCC(=O)N1 LIFNDDBLJFPEAN-BPSSIEEOSA-N 0.000 description 1
- RYNFEZONSOUYNZ-UHFFFAOYSA-N (4-amino-2-hydroxy-4-oxobutanoyl)sulfamic acid Chemical compound NC(=O)CC(O)C(=O)NS(O)(=O)=O RYNFEZONSOUYNZ-UHFFFAOYSA-N 0.000 description 1
- NMWKYTGJWUAZPZ-WWHBDHEGSA-N (4S)-4-[[(4R,7S,10S,16S,19S,25S,28S,31R)-31-[[(2S)-2-[[(1R,6R,9S,12S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,53S,56S,59S,62S,65S,68S,71S,76S,79S,85S)-47-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-18-(4-aminobutyl)-27,68-bis(3-amino-3-oxopropyl)-36,71,76-tribenzyl-39-(3-carbamimidamidopropyl)-24-(2-carboxyethyl)-21,56-bis(carboxymethyl)-65,85-bis[(1R)-1-hydroxyethyl]-59-(hydroxymethyl)-62,79-bis(1H-imidazol-4-ylmethyl)-9-methyl-33-(2-methylpropyl)-8,11,17,20,23,26,29,32,35,38,41,48,54,57,60,63,66,69,72,74,77,80,83,86-tetracosaoxo-30-propan-2-yl-3,4,44,45-tetrathia-7,10,16,19,22,25,28,31,34,37,40,49,55,58,61,64,67,70,73,75,78,81,84,87-tetracosazatetracyclo[40.31.14.012,16.049,53]heptaoctacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-7-(3-carbamimidamidopropyl)-25-(hydroxymethyl)-19-[(4-hydroxyphenyl)methyl]-28-(1H-imidazol-4-ylmethyl)-10-methyl-6,9,12,15,18,21,24,27,30-nonaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29-nonazacyclodotriacontane-4-carbonyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](Cc4ccccc4)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C)C(=O)N2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)C(=O)N[C@@H](C)C(O)=O NMWKYTGJWUAZPZ-WWHBDHEGSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- GOYDNIKZWGIXJT-UHFFFAOYSA-N 1,2-difluorobenzene Chemical class FC1=CC=CC=C1F GOYDNIKZWGIXJT-UHFFFAOYSA-N 0.000 description 1
- VILFTWLXLYIEMV-UHFFFAOYSA-N 1,5-difluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC([N+]([O-])=O)=C(F)C=C1F VILFTWLXLYIEMV-UHFFFAOYSA-N 0.000 description 1
- RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 description 1
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 description 1
- SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 description 1
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- ZMRMMAOBSFSXLN-UHFFFAOYSA-N 4-[4-(2,5-dioxopyrrol-1-yl)phenyl]butanehydrazide Chemical compound C1=CC(CCCC(=O)NN)=CC=C1N1C(=O)C=CC1=O ZMRMMAOBSFSXLN-UHFFFAOYSA-N 0.000 description 1
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- DNWRLMRKDSGSPL-UHFFFAOYSA-N 5-iodopyrimidine Chemical compound IC1=CN=CN=C1 DNWRLMRKDSGSPL-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241001448160 Acanthastrea ishigakiensis Species 0.000 description 1
- 241001230801 Acropora aspera Species 0.000 description 1
- 241000230526 Acropora austera Species 0.000 description 1
- 241000690804 Acropora carduus Species 0.000 description 1
- 241000031563 Acropora cerealis Species 0.000 description 1
- 241000690548 Acropora chesterfieldensis Species 0.000 description 1
- 241000413503 Acropora clathrata Species 0.000 description 1
- 241000230522 Acropora divaricata Species 0.000 description 1
- 241001480567 Acropora donei Species 0.000 description 1
- 241000690547 Acropora echinata Species 0.000 description 1
- 241001323469 Acropora globiceps Species 0.000 description 1
- 241000025391 Acropora grandis Species 0.000 description 1
- 241000690553 Acropora granulosa Species 0.000 description 1
- 241000546240 Acropora longicyathus Species 0.000 description 1
- 241001675023 Acropora loripes Species 0.000 description 1
- 241000977871 Acropora paniculata Species 0.000 description 1
- 241000690563 Acropora solitaryensis Species 0.000 description 1
- 241001223108 Acropora tenuis Species 0.000 description 1
- 241000230363 Acropora vaughani Species 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000055025 Adenosine deaminases Human genes 0.000 description 1
- 108091071248 Alpha family Proteins 0.000 description 1
- 102000040717 Alpha family Human genes 0.000 description 1
- 241000883984 Alveopora Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000625269 Astreopora gracilis Species 0.000 description 1
- 241001464438 Astreopora myriophthalma Species 0.000 description 1
- 208000025978 Athletic injury Diseases 0.000 description 1
- 241000039834 Australomussa rowleyensis Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 108091071247 Beta family Proteins 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 241001567848 Capitellum Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 206010007710 Cartilage injury Diseases 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- DQEFEBPAPFSJLV-UHFFFAOYSA-N Cellulose propionate Chemical compound CCC(=O)OCC1OC(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C1OC1C(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C(COC(=O)CC)O1 DQEFEBPAPFSJLV-UHFFFAOYSA-N 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 102000034573 Channels Human genes 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 101800001982 Cholecystokinin Proteins 0.000 description 1
- 102100025841 Cholecystokinin Human genes 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 201000005262 Chondroma Diseases 0.000 description 1
- 108010038061 Chymotrypsinogen Proteins 0.000 description 1
- 108010003422 Circulating Thymic Factor Proteins 0.000 description 1
- 208000003044 Closed Fractures Diseases 0.000 description 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
- 208000024779 Comminuted Fractures Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010011219 Costochondritis Diseases 0.000 description 1
- 241001362614 Crassa Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 208000012514 Cumulative Trauma disease Diseases 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 241000987266 Cynarina lacrymalis Species 0.000 description 1
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 208000032767 Device breakage Diseases 0.000 description 1
- 208000037408 Device failure Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241001022785 Distichopora violacea Species 0.000 description 1
- 206010014002 Ear deformity acquired Diseases 0.000 description 1
- 241000587742 Echinophyllia Species 0.000 description 1
- 241001041944 Echinophyllia echinata Species 0.000 description 1
- 241000204685 Echinopora Species 0.000 description 1
- 241000987250 Echinopora gemmacea Species 0.000 description 1
- 208000034715 Enchondroma Diseases 0.000 description 1
- 108010041308 Endothelial Growth Factors Proteins 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 206010053962 Epiphyseal fracture Diseases 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 241000205540 Euphyllia Species 0.000 description 1
- 241000205446 Euphyllia ancora Species 0.000 description 1
- 241000094980 Euphyllia divisa Species 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- 241000434252 Favia rotundata Species 0.000 description 1
- 241000009111 Favia truncatus Species 0.000 description 1
- 241000587738 Favites Species 0.000 description 1
- 241000987174 Favites halicora Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
- 102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 208000007356 Fracture Dislocation Diseases 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 241000539570 Galaxea acrhelia Species 0.000 description 1
- 102400000921 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 description 1
- 102000016354 Glucuronosyltransferase Human genes 0.000 description 1
- 108010092364 Glucuronosyltransferase Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000051366 Glycosyltransferases Human genes 0.000 description 1
- 108700023372 Glycosyltransferases Proteins 0.000 description 1
- 241000643969 Goniastrea edwardsi Species 0.000 description 1
- 241001154738 Goniastrea retiformis Species 0.000 description 1
- 241000563637 Goniopora albiconus Species 0.000 description 1
- 241000563636 Goniopora burgosi Species 0.000 description 1
- 241000094940 Goniopora columna Species 0.000 description 1
- 241001041942 Goniopora djiboutiensis Species 0.000 description 1
- 241000117492 Goniopora gracilis Species 0.000 description 1
- 241000349719 Goniopora lobata Species 0.000 description 1
- 241000498217 Goniopora minor Species 0.000 description 1
- 241000563630 Goniopora norfolkensis Species 0.000 description 1
- 241000349721 Goniopora pendulus Species 0.000 description 1
- 241000506853 Goniopora planulata Species 0.000 description 1
- 241001634346 Goniopora savignyi Species 0.000 description 1
- 241000563629 Goniopora somaliensis Species 0.000 description 1
- 241000117495 Goniopora stutchburyi Species 0.000 description 1
- 241001276031 Goniopora tenuidens Species 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000434255 Hydnophora pilosa Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 206010066386 Impacted fracture Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 208000002658 Intra-Articular Fractures Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 241000179167 Isididae Species 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 101710163560 Lamina-associated polypeptide 2, isoform alpha Proteins 0.000 description 1
- 101710189385 Lamina-associated polypeptide 2, isoforms beta/gamma Proteins 0.000 description 1
- 102000007547 Laminin Human genes 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 241001366451 Leptoseris explanata Species 0.000 description 1
- 241000204374 Leptoseris incrustans Species 0.000 description 1
- 241000978074 Leptoseris mycetoseroides Species 0.000 description 1
- 241000310339 Leptoseris scabra Species 0.000 description 1
- 241000094942 Leptoseris yabei Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000258818 Lithophyllon undulatum Species 0.000 description 1
- 241000205454 Lobophyllia hemprichii Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010072970 Meniscus injury Diseases 0.000 description 1
- 241000205510 Merulina scabricula Species 0.000 description 1
- 208000029725 Metabolic bone disease Diseases 0.000 description 1
- 241000498644 Millepora exaesa Species 0.000 description 1
- 241000204467 Montipora Species 0.000 description 1
- 241000978078 Montipora caliculata Species 0.000 description 1
- 241000204462 Montipora capitata Species 0.000 description 1
- 241000388063 Montipora foveolata Species 0.000 description 1
- 241000978075 Montipora meandrina Species 0.000 description 1
- 241001150445 Montipora tuberculosa Species 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 102000007981 Ornithine carbamoyltransferase Human genes 0.000 description 1
- 101710198224 Ornithine carbamoyltransferase, mitochondrial Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000010191 Osteitis Deformans Diseases 0.000 description 1
- 108090000573 Osteocalcin Proteins 0.000 description 1
- 102000004067 Osteocalcin Human genes 0.000 description 1
- 208000002804 Osteochondritis Diseases 0.000 description 1
- 206010031240 Osteodystrophy Diseases 0.000 description 1
- 206010031243 Osteogenesis imperfecta Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 102000004264 Osteopontin Human genes 0.000 description 1
- 108010081689 Osteopontin Proteins 0.000 description 1
- 108010035042 Osteoprotegerin Proteins 0.000 description 1
- 102000008108 Osteoprotegerin Human genes 0.000 description 1
- 241000987186 Oulophyllia Species 0.000 description 1
- 241000987259 Oxypora Species 0.000 description 1
- 241000987257 Oxypora lacera Species 0.000 description 1
- 208000027868 Paget disease Diseases 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 241000204385 Pavona Species 0.000 description 1
- 241000978159 Pavona venosa Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000205518 Pectinia Species 0.000 description 1
- 241000205516 Pectinia alcicornis Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 102100037883 Phospholipase B1, membrane-associated Human genes 0.000 description 1
- 108010058864 Phospholipases A2 Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 241001257016 Platyphylla Species 0.000 description 1
- 241000258816 Pleuractis granulosa Species 0.000 description 1
- 241000115055 Podabacia Species 0.000 description 1
- 206010065159 Polychondritis Diseases 0.000 description 1
- 229920001273 Polyhydroxy acid Polymers 0.000 description 1
- 241000327095 Porites annae Species 0.000 description 1
- 241000587736 Porites cylindrica Species 0.000 description 1
- 241001497373 Porites evermanni Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 241000115115 Psammocora digitata Species 0.000 description 1
- 241000115116 Psammocora explanulata Species 0.000 description 1
- 241001206252 Psammocora haimiana Species 0.000 description 1
- 241000115117 Psammocora superficialis Species 0.000 description 1
- 208000002607 Pseudarthrosis Diseases 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 229920002305 Schizophyllan Polymers 0.000 description 1
- 241000242732 Scleractinia Species 0.000 description 1
- 102100037505 Secretin Human genes 0.000 description 1
- 108010086019 Secretin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 102000005157 Somatostatin Human genes 0.000 description 1
- 108010056088 Somatostatin Proteins 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 206010041738 Sports injury Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000475042 Stolonifera Species 0.000 description 1
- 208000013201 Stress fracture Diseases 0.000 description 1
- 241001022751 Stylaster Species 0.000 description 1
- 241000498649 Stylasteridae Species 0.000 description 1
- 241000978167 Stylocoeniella armata Species 0.000 description 1
- 241001150439 Stylocoeniella guentheri Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 101710185318 Thymic factor Proteins 0.000 description 1
- 102400000159 Thymopoietin Human genes 0.000 description 1
- 239000000898 Thymopoietin Substances 0.000 description 1
- 208000026317 Tietze syndrome Diseases 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 102400001320 Transforming growth factor alpha Human genes 0.000 description 1
- 101800004564 Transforming growth factor alpha Proteins 0.000 description 1
- 108060008539 Transglutaminase Proteins 0.000 description 1
- 102000018690 Trypsinogen Human genes 0.000 description 1
- 108010027252 Trypsinogen Proteins 0.000 description 1
- 241000006732 Tubipora Species 0.000 description 1
- 241000006735 Tubipora musica Species 0.000 description 1
- 241000006373 Turbinaria <Phaeophyceae> Species 0.000 description 1
- 229920002310 Welan gum Polymers 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229920013820 alkyl cellulose Polymers 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000002870 angiogenesis inducing agent Substances 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000037873 arthrodesis Diseases 0.000 description 1
- 238000011882 arthroplasty Methods 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 229920013641 bioerodible polymer Polymers 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 229940019700 blood coagulation factors Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000010504 bond cleavage reaction Methods 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 230000018678 bone mineralization Effects 0.000 description 1
- 230000008416 bone turnover Effects 0.000 description 1
- 210000000984 branchial region Anatomy 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003848 cartilage regeneration Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000012832 cell culture technique Methods 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008614 cellular interaction Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229920006218 cellulose propionate Polymers 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940107137 cholecystokinin Drugs 0.000 description 1
- 230000009816 chondrogenic differentiation Effects 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 201000005043 chondromalacia Diseases 0.000 description 1
- 230000012085 chronic inflammatory response Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 108010045512 cohesins Proteins 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 229920001795 coordination polymer Polymers 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZLFRJHOBQVVTOJ-UHFFFAOYSA-N dimethyl hexanediimidate Chemical compound COC(=N)CCCCC(=N)OC ZLFRJHOBQVVTOJ-UHFFFAOYSA-N 0.000 description 1
- LRPQMNYCTSPGCX-UHFFFAOYSA-N dimethyl pimelimidate Chemical compound COC(=N)CCCCCC(=N)OC LRPQMNYCTSPGCX-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- ZWIBGKZDAWNIFC-UHFFFAOYSA-N disuccinimidyl suberate Chemical compound O=C1CCC(=O)N1OC(=O)CCCCCCC(=O)ON1C(=O)CCC1=O ZWIBGKZDAWNIFC-UHFFFAOYSA-N 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 230000000913 erythropoietic effect Effects 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 201000010103 fibrous dysplasia Diseases 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 210000004349 growth plate Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 238000011540 hip replacement Methods 0.000 description 1
- 210000003035 hyaline cartilage Anatomy 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 150000002463 imidates Chemical class 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229920000592 inorganic polymer Polymers 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 238000013150 knee replacement Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 208000027202 mammary Paget disease Diseases 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 231100000782 microtubule inhibitor Toxicity 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000004079 mineral homeostasis Effects 0.000 description 1
- 230000000921 morphogenic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003349 osteoarthritic effect Effects 0.000 description 1
- 208000007656 osteochondritis dissecans Diseases 0.000 description 1
- 230000009818 osteogenic differentiation Effects 0.000 description 1
- 230000000010 osteolytic effect Effects 0.000 description 1
- 230000001009 osteoporotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 210000004623 platelet-rich plasma Anatomy 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229940065514 poly(lactide) Drugs 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 229920000548 poly(silane) polymer Polymers 0.000 description 1
- 229920000070 poly-3-hydroxybutyrate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001299 polypropylene fumarate Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 230000034918 positive regulation of cell growth Effects 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 229920013730 reactive polymer Polymers 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229960002101 secretin Drugs 0.000 description 1
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- RPENMORRBUTCPR-UHFFFAOYSA-M sodium;1-hydroxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].ON1C(=O)CC(S([O-])(=O)=O)C1=O RPENMORRBUTCPR-UHFFFAOYSA-M 0.000 description 1
- 229960000553 somatostatin Drugs 0.000 description 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000007838 tissue remodeling Effects 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 102000003601 transglutaminase Human genes 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000032665 vasculature development Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/1604—Chisels; Rongeurs; Punches; Stamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
- F25D—REFRIGERATORS; COLD ROOMS; ICE-BOXES; COOLING OR FREEZING APPARATUS NOT OTHERWISE PROVIDED FOR
- F25D5/00—Devices using endothermic chemical reactions, e.g. using frigorific mixtures
- F25D5/02—Devices using endothermic chemical reactions, e.g. using frigorific mixtures portable, i.e. adapted to be carried personally
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/1613—Component parts
- A61B17/1615—Drill bits, i.e. rotating tools extending from a handpiece to contact the worked material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/1613—Component parts
- A61B17/1633—Sleeves, i.e. non-rotating parts surrounding the bit shaft, e.g. the sleeve forming a single unit with the bit shaft
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/1662—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans for particular parts of the body
- A61B17/1675—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans for particular parts of the body for the knee
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/17—Guides or aligning means for drills, mills, pins or wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/17—Guides or aligning means for drills, mills, pins or wires
- A61B17/1739—Guides or aligning means for drills, mills, pins or wires specially adapted for particular parts of the body
- A61B17/1764—Guides or aligning means for drills, mills, pins or wires specially adapted for particular parts of the body for the knee
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30756—Cartilage endoprostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2/4601—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for introducing bone substitute, for implanting bone graft implants or for compacting them in the bone cavity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2/4603—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof
- A61F2/4618—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof of cartilage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/10—Cooling bags, e.g. ice-bags
- A61F7/106—Cooling bags, e.g. ice-bags self-cooling, e.g. using a chemical reaction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
- B65D81/3261—Flexible containers having several compartments
- B65D81/3266—Flexible containers having several compartments separated by a common rupturable seal, a clip or other removable fastening device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/88—Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
- A61B17/92—Impactors or extractors, e.g. for removing intramedullary devices
- A61B2017/922—Devices for impaction, impact element
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2835—Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2835—Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
- A61F2002/2839—Bone plugs or bone graft dowels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/30199—Three-dimensional shapes
- A61F2002/30205—Three-dimensional shapes conical
- A61F2002/3021—Three-dimensional shapes conical frustoconical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/30199—Three-dimensional shapes
- A61F2002/30273—Three-dimensional shapes pyramidal
- A61F2002/30276—Three-dimensional shapes pyramidal frustopyramidal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30795—Blind bores, e.g. of circular cross-section
- A61F2002/30807—Plurality of blind bores
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2002/3093—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth for promoting ingrowth of bone tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0052—Body part for treatment of skin or hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0268—Compresses or poultices for effecting heating or cooling having a plurality of compartments being filled with a heat carrier
- A61F2007/0269—Compresses or poultices for effecting heating or cooling having a plurality of compartments being filled with a heat carrier with separable compartments, e.g. reconnectable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0268—Compresses or poultices for effecting heating or cooling having a plurality of compartments being filled with a heat carrier
- A61F2007/0269—Compresses or poultices for effecting heating or cooling having a plurality of compartments being filled with a heat carrier with separable compartments, e.g. reconnectable
- A61F2007/0271—Permanently separable compartments, e.g. with rupturable portions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00341—Coral, e.g. aragonite, porite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dentistry (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Thermal Sciences (AREA)
- Mechanical Engineering (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Botany (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Combustion & Propulsion (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Surgical Instruments (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
本出願は、2015年5月6日に出願された米国仮出願第62/157,485号及び2016年5月4日に出願された米国仮出願第62/331,471号の利益を主張するものであり、その各々の全体を参照により本明細書中に完全に取り込む。
例えば、外傷、新形成、異常組織成長、老化などに曝された結果として、組織の機能を回復しそして形態を再構築するために、組織の成長、再生及び修復がしばしば必要である。
幾つかの実施形態において、本発明は細胞もしくは組織の成長又は回復した機能を促進するための最適化された固体基材を提供する。幾つかの実施形態において、本発明は、それとともに使用するためのツール及びその使用方法を提供する。
*長尺体の長さにわたる中央中空を有する長尺体、
*中央中空を有する接合領域によって前記長尺体に末端結合された整形構造体であって、
〇前記接合領域に対して近位にある第一の整形領域、ここで、該第一の整形領域は実質的に滑らかであり、平行配向された側面又は前記ツールの長手方向軸からある角度でテーパー化された側面を有する、及び、
〇前記接合領域に対して遠位にある第二の整形領域、ここで、該第二の整形領域は一連の側方延在突出部を含み、そして前記ツールの長手方向軸からある角度でテーパー側面を有する、
をさらに含む、整形構造体、及び、
*場合により、前記整形構造体に対して遠位に配置された接合領域によって前記長尺体に末端結合された把持ハンドル、
を含み、
前記整形構造体は移植部位の境界内に滑り嵌めするのを容易にする寸法を有するようにサイズ決めされている。
・細胞もしくは組織の成長又は回復した機能を促進するための最適化された固体基材を単離又は調製すること、ここで、該固体基材はサンゴ又はサンゴ誘導体を含み、少なくとも75%の比流体吸収能力値を特徴とし、又は、60度未満の接触角値を有することを特徴とし、そして、該固体基材の端部での少なくとも1つの実質的に平坦な断面及びテーパー側面をさらに特徴とする、
・前記固体基材の比流体吸収能力値を確立すること、ここで、前記比流体吸収能力値は、自発的流体吸収値を総流体吸収値で割った値を確立することによって決定される、
・少なくとも75%の比流体吸収能力値を特徴とするか、又は、60度未満の接触角値を有することを特徴とする固体基材を選択すること、及び、
・少なくとも75%の比流体吸収能力値を特徴とするか、又は、60度未満の接触角値を有することを特徴とする前記固体基材を、対象の所望の部位内で移植すること、ここで、前記移植はこのように処置される組織部位の表面に対して垂直な軸からある角度で行われる、
を含む方法を提供する。
・細胞もしくは組織の成長又は回復した機能を促進するための最適化された固体基材を単離又は調製すること、ここで、該固体基材はサンゴ又はサンゴ誘導体を含み、少なくとも75%の比流体吸収能力値を特徴とし、又は、60度未満の接触角値を有することを特徴とし、そして、該固体基材に沿った長手方向軸から0.75~約4度の角度でテーパー側面を含むことをさらに特徴とする、
・前記固体基材の比流体吸収能力値を確立すること、ここで、前記比流体吸収能力値は、自発的流体吸収値を総流体吸収値で割った値を確立することによって決定される、
・少なくとも75%の比流体吸収能力値を特徴とするか、又は、60度未満の接触角値を有することを特徴とする固体基材を選択すること、及び、
・少なくとも75%の比流体吸収能力値を特徴とするか、又は、60度未満の接触角値を有することを特徴とする前記固体基材を、対象の所望の部位内で移植すること、ここで、前記移植はこのように処置される組織部位の表面に対して垂直な軸から0.75~約4度の移植角度で行われる、
を含む方法を提供する。
・前記標的移植片離脱又は移植部位の表面の平面に対して垂直な方向にそして移植部位内で中心に集める方向にロッド状構造体を向ける器具の助けを場合により借りて、対象内の標的組織移植部位内にロッド状構造体を挿入すること、
・組織の領域の表面に対して垂直な方向で所望の組織移植部位の領域よりも小さい前記対象内の組織の領域を、前記ロッド状構造体の上に適用するのに適したドリルビットを場合により用いて穴開けすること、
・前記ロッド状構造体の上に外科用カッターを場合により適用することによって、所望の移植領域から組織を外科的に切除すること、
・組織整形及び位置合わせツールの助けを借りて前記所望の移植領域を整形すること、ここで、前記組織整形及び位置合わせツールは、
*長尺体の長さにわたる中央中空を有する長尺体、
*中央中空を有する接合領域によって前記長尺体に末端結合された整形構造体であって、
〇前記接合領域に対して近位にある第一の整形領域、ここで、該第一の整形領域は実質的に滑らかであり、平行配向された側面又は前記ツールの長手方向軸からある角度でテーパー化された側面を有する、及び、
〇前記接合領域に対して遠位にある第二の整形領域、ここで、該第二の整形領域は一連の側方延在突出部を含み、そして前記ツールの長手方向軸からある角度でテーパー側面を有する、
をさらに含む、整形構造体、及び、
*場合により、前記整形構造体に対して遠位にある接合領域によって前記長尺体に末端結合された把持ハンドル、
を含む、
前記整形構造体は移植部位の境界内に滑り嵌めするのを容易にする寸法を有するようにサイズ決めされている、
・前記ロッド状構造体の上で所望の移植の前記領域内にカニューレ移植片を場合によって挿入することによって、組織の前記領域内に組織移植片又は固体移植片を適用すること、
の工程をさらに含み、
前記整形は移植部位を通して長手方向軸からある角度でテーパー側面を有する部位の形成を促進し、前記固体移植片の理想的な取り込みを促進する。
・湾曲した位置合わせ及び配置組織摘出ベースが固定される組織の曲率半径に相補的な曲率半径を有するベース表面、
・それぞれのロッド状構造体が挿入されることができる少なくとも2つの外側に位置する側方延在部をさらに含む、形状が実質的に卵形である外側境界部、及び、
・前記湾曲した位置合わせ及び配置組織摘出ベースの長さにわたる少なくとも2つの内側に位置する中空領域、
を含む。
・長尺中空シャフト、
・前記長尺中空シャフトの第一の末端に位置するロッキング先端部、ここで、前記ロッキング先端部は、本明細書に記載のとおりの湾曲した位置合わせ及び配置組織摘出ベースの内部でロッキング機構挿入構造体内に挿入する、外側に位置する延在部を含む、及び、
・長尺中空シャフトの第二の末端に配置された又はそれに取り付けられたヘッドピース、
を含む。
・少なくとも1つの長尺シャフトの長さにわたる少なくとも1つの中央中空を含む少なくとも1つの長尺シャフト、
・末端グリップの長さにわたりそして前記少なくとも1つの長尺シャフトの長さにわたる少なくとも1つの中央中空と整列している少なくとも1つの中空領域を有する、末端グリップ、及び、
・挿入ベースの長さにわたりそして前記少なくとも1つの長尺シャフトの長さにわたる少なくとも1つの中央中空と整列している少なくとも1つの中空領域を有し、さらに形状が実質的に卵形であり、本明細書に記載のとおりの、湾曲した位置合わせ及び配置組織摘出ベース内に挿入することができるサイズである、挿入ベース、
を含む。
・少なくとも1つの長尺シャフトの長さにわたり、ドリルビットの挿入及び内部での前記ドリルビットの回転に適合するようにサイズ決めされた少なくとも1つの中央中空を含む、少なくとも1つの長尺シャフト、
・トップ部分の長さにわたりそして前記少なくとも1つの長尺シャフトの長さにわたる前記少なくとも1つの中央中空と整列している少なくとも1つの中央中空を有する、トップ部分、及び、
・挿入ベースの長さにわたりそして前記少なくとも1つの長尺シャフトの長さにわたる前記少なくとも1つの中央中空と整列している少なくとも1つの中央中空領域を有し、さらに、湾曲した位置合わせ及び配置組織摘出ベース内に挿入することができるサイズである挿入ベース、
を含む。
・ロッド状構造体を挿入することができる、前記輪郭カッターの長さにわたる中央中空、
・形状が実質的に卵形である外側境界、及び、
・前記輪郭カッター内で上昇及び下降されうるように前記外側境界に摺動可能に取り付けられた少なくとも1つのブレード構造体、及び、場合により、
・第二のロッド状構造体の挿入のための少なくとも1つの中空ハウジング、
を含む。
・形状が実質的に卵形である外側境界、及び、湾曲した位置合わせ及び配置組織摘出ベースが取り付けられている組織の曲率半径に相補的な曲率半径を備えるベース表面を有し、前記ベース表面の露出した領域の少なくとも一部の上に非粘着性材料を含む、第一の領域、
・前記第一の領域の遠位にある把持部を含む第二の領域、及び、
・前記第一の領域と前記第二の領域との間に配置された長尺シャフト、
を含む。
本発明は、とりわけ、細胞もしくは組織の成長又は回復した機能を促進するための最適化された固体基材、それとともに使用するためのツール及びその使用を提供する。
*長尺体の長さにわたる中央中空を有する長尺体、
*中央中空を有する接合領域によって前記長尺体に末端結合された整形構造体であって、
〇前記接合領域に対して近位にある第一の整形領域、ここで、該第一の整形領域は実質的に滑らかであり、平行配向された側面又は前記ツールの長手方向軸からある角度でテーパー化された側面を有する、及び、
〇前記接合領域に対して遠位にある第二の整形領域、ここで、該第二の整形領域は一連の側方延在突出部を含み、そして前記ツールの長手方向軸からある角度でテーパー側面を有する、
をさらに含む、整形構造体、及び、
*場合により、前記整形構造体に対して遠位にある接合領域によって前記長尺体に末端結合された把持ハンドル、
を含み、
前記整形構造体は移植部位の境界内に滑り嵌めするのを容易にする寸法を有するようにサイズ決めされている。
・細胞もしくは組織の成長又は回復した機能を促進するための最適化された固体基材を単離又は調製すること、ここで、該固体基材はサンゴ又はサンゴ誘導体を含み、少なくとも75%の比流体吸収能力値を特徴とし、又は、60度未満の接触角値を有することを特徴とし、そして、該固体基材の各末端での円形断面及びテーパー側面を有する実質的に円錐形状であることをさらに特徴とする、
・前記固体基材の比流体吸収能力値を確立すること、ここで、前記比流体吸収能力値は、自発的流体吸収値を総流体吸収値で割った値を確立することによって決定される、
・少なくとも75%の比流体吸収能力値を特徴とするか、又は、60度未満の接触角値を有することを特徴とする固体基材を選択すること、及び、
・少なくとも75%の比流体吸収能力値を特徴とするか、又は、60度未満の接触角値を有することを特徴とする前記固体基材を、対象の所望の部位内で移植すること、ここで、前記移植はこのように処置される組織部位の表面に対して垂直な軸から2度の角度で行われる、方法を提供する。
・前記標的移植片離脱又は移植部位の表面の平面に対して垂直な方向にそして移植部位内で中心に集める方向にロッド状構造体を向ける器具の助けを場合により借りて、対象内の標的組織移植部位内にロッド状構造体を挿入すること、
・組織の領域の表面に対して垂直な方向で所望の組織移植部位の領域よりも小さい前記対象内の組織の領域を、前記ロッド状構造体の上に適用するのに適したドリルビットを場合により用いて穴開けすること、
・前記ロッド状構造体の上に外科用カッターを場合により適用することによって、所望の移植領域から組織を外科的に切除すること、
・組織整形及び位置合わせツールの助けを借りて前記所望の移植領域を整形すること、ここで、前記組織整形及び位置合わせツールは、
*長尺体の長さにわたる中央中空を有する長尺体、
*中央中空を有する接合領域によって前記長尺体に末端結合された整形構造体であって、
〇前記接合領域に対して近位にある第一の整形領域、ここで、該第一の整形領域は実質的に滑らかであり、平行配向された側面又は前記ツールの長手方向軸から2度の角度でテーパー化された側面を有する、及び、
〇前記接合領域に対して遠位にある第二の整形領域、ここで、該第二の整形領域は一連の側方延在突出部を含み、そして前記ツールの長手方向軸から2度の角度でテーパー側面を有する、
をさらに含む、整形構造体、及び、
*場合により、前記整形構造体に対して遠位にある接合領域によって前記長尺体に末端結合された把持ハンドル、
を含み、
前記整形構造体は移植部位の境界内に滑り嵌めするのを容易にする寸法を有するようにサイズ決めされている、
・前記ロッド状構造体の上で前記所望の移植領域内にカニューレインプラントを場合によって挿入することによって、組織の前記領域内に組織移植片又は固体移植片を適用すること、
の工程をさらに含み、
前記整形は前記固体移植片の理想的な取り込みを促進する移植部位を通して長手方向軸から2度の角度でテーパー側面を有する部位の形成を促進する。
・前記湾曲した位置合わせ及び配置組織摘出ベースが固定される組織の曲率半径に相補的な曲率半径を有するベース表面、
・それぞれのロッド状構造体が挿入されることができる少なくとも2つの外側に位置する側方延在部をさらに含む、形状が実質的に卵形である外側境界部、及び、
・前記湾曲した位置合わせ及び配置組織摘出ベースの長さにわたる少なくとも2つの内側に位置する中空領域、
を含む。
・少なくとも1つの長尺シャフトの長さにわたり、ドリルビットの挿入及びその内部でのドリルビットの回転に適合するようにサイズ決めされた、少なくとも1つの中央中空を含む、少なくとも1つの長尺シャフト、
・トップ部分の長さにわたる少なくとも1つの中央中空であって、前記少なくとも1つの長尺シャフトの長さにわたる前記少なくとも1つの中央中空と整列している少なくとも1つの中央中空を有するトップ部分、及び、
・挿入ベースの長さにわたる少なくとも1つの中央中空領域であって、前記少なくとも1つの長尺シャフトの長さにわたる前記少なくとも1つの中央中空と整列している、少なくとも1つの中央中空領域を有し、本明細書に規定されるとおりの湾曲した位置合わせ及び配置組織摘出ベース内に挿入することができるサイズである挿入ベース、
を含む。
・ロッド状構造体を挿入することができる、前記輪郭カッターの長さにわたる中央中空、
・形状が実質的に卵形である外側境界、及び、
・少なくとも1つのブレード構造体であって、前記輪郭カッター内で上下に動くことができるように前記外側境界に摺動可能に取り付けられたブレード構造体、及び、
・場合により、第二のロッド状構造体を挿入するための、少なくとも1つの中空ハウジング、
を含む。
・形状が実質的に卵形の外側境界、及び、湾曲した位置合わせ及び配置組織摘出ベースが取り付けられる組織の曲率半径に相補的な曲率半径を含むベース表面を有し、そして前記ベース表面の露出領域の少なくとも一部の上に非粘着材料を含む、第一の領域、
・前記第一の領域の遠位にある把持部を含む、第二の領域、及び、
・前記第一の領域と前記第二の領域との間に配置された長尺シャフト、
を含む。
・細胞もしくは組織の成長又は回復した機能を促進するための最適化された固体基材を単離又は調製すること、ここで、該固体基材はサンゴ又はサンゴ誘導体を含み、少なくとも75%の比流体吸収能力値を特徴とし、又は、60度未満の接触角値を有し、そして、該固体基材が適用される組織表面の曲率半径に相補的である曲率半径をさらに含むことを特徴とする、
・前記固体基材の比流体吸収能力値を確立すること、ここで、前記比流体吸収能力値は、自発的流体吸収値を総流体吸収値で割った値を確立することによって決定される、
・少なくとも75%の比流体吸収能力値を特徴とするか、又は、60度未満の接触角値を有することを特徴とする固体基材を選択すること、及び、
・少なくとも75%の比流体吸収能力値を特徴とするか、又は、60度未満の接触角値を有することを特徴とする前記固体基材を、対象の所望の部位内で移植すること、ここで、前記移植は、本明細書に記載のとおりの輪郭カッター、本明細書に記載のとおりの湾曲した位置合わせ及び配置組織摘出ベース、本明細書に記載のとおりのロッカー、本明細書に記載のとおりの垂直移植アライナ、本明細書に記載のとおりのドリルビット保護シース、本明細書に記載のとおりのタンパー又はそれらのいずれかの組み合わせのうちの少なくとも1つを使用することにより行われる、
を含む、方法を提供する。
例1
本発明の最適化されたサンゴをベースとする固体基材の調製
材料及び方法
ダイヤモンドソーを使用して外側のサンゴ層を除去し、そしてそこからより大きな部分を切り取り、サンゴブロックから所望の寸法の代表的なより小さい部分を切り取った。
本発明のサンゴ系固体基材において長手方向軸に沿って特に2度の角度でテーパー化された側面の存在の関数として改良された固体基材の取り込み
例1のプラグにおける構造変化性の結果を評価するために、サンゴプラグを例1に記載されるように調製した。
最適化された実質的に円錐形のサンゴ系固体基材の移植のためのツール及び理想的移植手順
例2に記載のとおりの最適化された基材を欠損部位に移植することができる。そしてかかる移植片は、実質的に円錐形である移植片の側面を2度の最適テーパー角を維持しながら、サイズに合わせて拡大縮小されうることが理解されるであろう。
関節丘内の最適化されたサンゴ系固体基材の移植のためのツール及び理想的な移植手順
例2に記載されるとおりの最適化された基材などの基材を欠損部に移植することができる。そしてかかる移植片は、実質的に円錐形である移植片の側面を2度の最適テーパー角を維持しながら、サイズに合わせて拡大縮小されうることが理解されるであろう。
関節丘内の最適化された固体基材の移植のための理想的な移植手順のためのカスタマイズされたツール及び移植片
基材、例えば、例2に記載のとおりの最適化された基材を欠損部位に移植することができ、このような移植片を拡大縮小されうることが理解されるであろう。幾つかの態様において、移植片の側面に対して2度の最適なテーパー角は導入されるであろう。幾つかの態様において、このような移植片は全体の寸法に対してさらに最適化され、また、欠損部位の曲率半径に近似する曲率半径であろう。
Claims (25)
- 細胞もしくは組織の成長又は回復した機能を促進するための最適化された固体基材であって、該固体基材はサンゴ又はサンゴ誘導体を含み、少なくとも75%の比流体吸収能力値を特徴とし、又は、流体との接触時に60度未満の接触角値を有することを特徴とし、そして該固体基材は:
該固体基材の末端での少なくとも1つの実質的に平坦な断面;
円錐もしくは角錐台形状;及び
該固体基材に沿った長手方向軸から0.75~4度の角度でのテーパー側面;
をさらに特徴とする、固体基材。 - 細胞もしくは組織の成長又は回復した機能を促進するための最適化された固体基材であって、該固体基材はサンゴ又はサンゴ誘導体を含み、少なくとも75%の比流体吸収能力値を特徴とし、又は、流体との接触時に60度未満の接触角値を有することを特徴とし、そして該固体基材は:
円錐もしくは角錐台形状;及び
該固体基材に沿った長手方向軸から0.75~4度の角度でのテーパー側面;
をさらに特徴とする、固体基材。 - 前記テーパー側面は前記固体基材に沿った長手方向軸から2度の角度である、請求項1又は2記載の固体基材。
- 前記固体基材はポリテス(Porites)種、ゴニオポラ(Goniopora)種、ミレポラ(Millepora)種又はアクロポラ(Acropora)種から単離される、請求項1又は2記載の固体基材。
- 前記固体基材は前記固体基材のデカルト座標軸に沿った1つ又は複数の中空を含む、請求項1又は2記載の固体基材。
- 前記固体基材は生体適合性ポリマーを含む、請求項1又は2記載の固体基材。
- 前記生体適合性ポリマーは前記基材の中の空隙又は細孔の内部に取り込まれる、請求項6記載の固体基材。
- 前記生体適合性ポリマーは前記基材の外側表面に付着されている、請求項6記載の固体基材。
- 前記生体適合性ポリマーは前記固体基材の端部と結合している分離相中に存在している、請求項6記載の固体基材。
- 前記生体適合性ポリマーは天然ポリマーを含む、請求項6記載の固体基材。
- 前記天然ポリマーがアルギン酸塩を含有する、請求項10記載の固体基材。
- 前記天然ポリマーがキトサンを含有する、請求項10記載の固体基材。
- 前記天然ポリマーがグリコサミノグリカンを含有する、請求項10記載の固体基材。
- 前記固体基材はサイトカイン、成長因子、治療化合物、薬物又はそれらのいずれかの組み合わせをさらに含む、請求項1又は2記載の固体基材。
- 前記固体基材は高さが5~40mmである、請求項1又は2記載の固体基材。
- 前記固体基材は高さが1cm~5cmである、請求項1又は2記載の固体基材。
- 請求項1又は2記載の固体基材を少なくとも1つ含むキット。
- 前記キットは生体適合性ポリマーをさらに含む、請求項17記載のキット。
- 前記生体適合性ポリマーはヒアルロン酸である、請求項18記載のキット。
- 細胞もしくは組織の成長又は回復した機能を促進するための最適化された固体基材の移植を必要とする対象におけるその移植方法に使用するための固体基材であって、当該固体基材が、細胞もしくは組織の成長又は回復した機能を促進するための最適化された固体基材であって、該固体基材はサンゴ又はサンゴ誘導体を含み、少なくとも75%の比流体吸収能力値を特徴とし、又は、60度未満の接触角値を有することを特徴とし、そして、該固体基材の末端での少なくとも1つの実質的に平坦な断面及び該固体基材に沿った長手方向軸から0.75~4度の角度でのテーパー側面をさらに特徴とし、該方法が、以下;
・前記固体基材の比流体吸収能力値を確立する工程、ここで、前記比流体吸収能力値は、自発的流体吸収値を総流体吸収値で割った値を確立することによって決定される;
・少なくとも75%の比流体吸収能力値を特徴とするか、又は、60度未満の接触角値を有することを特徴とする固体基材を選択する工程;及び、
・少なくとも75%の比流体吸収能力値を特徴とするか、又は、60度未満の接触角値を有することを特徴とする前記固体基材を、対象の所望の部位内で移植する工程、ここで、前記移植はこのように処置される組織部位の表面に対して垂直な軸からある角度で行われる;
を含み、該固体基材が、円錐もしくは角錐台形状を特徴とする、固体基材。 - 前記天然ポリマーが、グリコサミノグリカン、コラーゲン、フィブリン、エラスチン、絹、キトサン、アルギン酸塩及びそれらの任意の組合せを含む、請求項10記載の固体基材。
- 前記アルギン酸塩が、アルギン酸カルシウム、架橋アルギン酸カルシウム又はそれらの組合せを含む、請求項11記載の固体基材。
- 前記キトサンが架橋キトサンを含む、請求項12記載の固体基材。
- 前記グリコサミノグリカンが、ヒアルロン酸、ヒアルロン酸ナトリウム、架橋ヒアルロン酸又はそれらの組合せである、請求項13記載の固体基材。
- 前記固体基材が同種移植片又は自己移植片である、請求項1又は2記載の固体基材。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021047410A JP2021112572A (ja) | 2015-05-06 | 2021-03-22 | 最適化された固体基材、それとともに使用するためのツールならびに細胞及び組織の成長を促進するためのその使用 |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562157485P | 2015-05-06 | 2015-05-06 | |
US62/157,485 | 2015-05-06 | ||
US201662331471P | 2016-05-04 | 2016-05-04 | |
PCT/IL2016/050469 WO2016178226A1 (en) | 2015-05-06 | 2016-05-04 | Optimized solid substrates, tools for use with same and uses thereof for promoting cell and tissue growth |
US62/331,471 | 2016-05-04 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021047410A Division JP2021112572A (ja) | 2015-05-06 | 2021-03-22 | 最適化された固体基材、それとともに使用するためのツールならびに細胞及び組織の成長を促進するためのその使用 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2018520712A JP2018520712A (ja) | 2018-08-02 |
JP2018520712A5 JP2018520712A5 (ja) | 2019-06-13 |
JP7143079B2 true JP7143079B2 (ja) | 2022-09-28 |
Family
ID=57218481
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017554568A Active JP7143079B2 (ja) | 2015-05-06 | 2016-05-04 | 最適化された固体基材、それとともに使用するためのツールならびに細胞及び組織の成長を促進するためのその使用 |
JP2021047410A Pending JP2021112572A (ja) | 2015-05-06 | 2021-03-22 | 最適化された固体基材、それとともに使用するためのツールならびに細胞及び組織の成長を促進するためのその使用 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021047410A Pending JP2021112572A (ja) | 2015-05-06 | 2021-03-22 | 最適化された固体基材、それとともに使用するためのツールならびに細胞及び組織の成長を促進するためのその使用 |
Country Status (8)
Country | Link |
---|---|
US (2) | US11007304B2 (ja) |
JP (2) | JP7143079B2 (ja) |
KR (1) | KR20180003587A (ja) |
AU (3) | AU2016259201B2 (ja) |
CA (1) | CA2973549A1 (ja) |
IL (1) | IL255447B2 (ja) |
WO (1) | WO2016178226A1 (ja) |
ZA (1) | ZA201705050B (ja) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8388624B2 (en) | 2003-02-24 | 2013-03-05 | Arthrosurface Incorporated | Trochlear resurfacing system and method |
EP1765201A4 (en) | 2004-06-28 | 2013-01-23 | Arthrosurface Inc | SYSTEM FOR THE BENDING AREA |
AU2007332787A1 (en) | 2006-12-11 | 2008-06-19 | Arthrosurface Incorporated | Retrograde resection apparatus and method |
WO2010121250A1 (en) | 2009-04-17 | 2010-10-21 | Arthrosurface Incorporated | Glenoid resurfacing system and method |
US10945743B2 (en) | 2009-04-17 | 2021-03-16 | Arthrosurface Incorporated | Glenoid repair system and methods of use thereof |
DK2442749T3 (da) | 2009-06-15 | 2019-05-27 | Cartiheal 2009 Ltd | Faste former til reparation af væv |
BR112012022482A2 (pt) | 2010-03-05 | 2016-07-19 | Arthrosurface Inc | sistema e método de recomposição da superfície tibial. |
EP2804565B1 (en) | 2011-12-22 | 2018-03-07 | Arthrosurface Incorporated | System for bone fixation |
HUE046178T2 (hu) | 2012-05-17 | 2020-02-28 | Cartiheal 2009 Ltd | Biomátrix hidrogélek és alkalmazási eljárásaik |
DE112013003358T5 (de) * | 2012-07-03 | 2015-03-19 | Arthrosurface, Inc. | System und Verfahren für Gelenkoberflächenersatz und -reparatur |
KR102248576B1 (ko) | 2013-02-13 | 2021-05-06 | 카티힐 (2009) 엘티디. | 세포 및 조직 성장을 촉진하기 위한 고체 기질 |
US9492200B2 (en) | 2013-04-16 | 2016-11-15 | Arthrosurface Incorporated | Suture system and method |
US11607319B2 (en) | 2014-03-07 | 2023-03-21 | Arthrosurface Incorporated | System and method for repairing articular surfaces |
US10624748B2 (en) | 2014-03-07 | 2020-04-21 | Arthrosurface Incorporated | System and method for repairing articular surfaces |
US9931219B2 (en) | 2014-03-07 | 2018-04-03 | Arthrosurface Incorporated | Implant and anchor assembly |
US20190358042A1 (en) * | 2018-05-25 | 2019-11-28 | In2Bones Usa, Llc | Tapered Osteochondral Implant |
WO2016178226A1 (en) * | 2015-05-06 | 2016-11-10 | Cartiheal (2009) Ltd | Optimized solid substrates, tools for use with same and uses thereof for promoting cell and tissue growth |
CA3108761A1 (en) | 2017-08-04 | 2019-02-07 | Arthrosurface Incorporated | Multicomponent articular surface implant |
WO2019135216A1 (en) | 2018-01-02 | 2019-07-11 | Cartiheal (2009) Ltd. | Implantation tool and protocol for optimized solid substrates promoting cell and tissue growth |
IT201800002658A1 (it) * | 2018-02-13 | 2019-08-13 | Surgical Clinicare S R L | Dispositivo per impianto nello spazio intervertebrale e uso di matrice per impianti ossei in chirurgia vertebrale |
US11478358B2 (en) | 2019-03-12 | 2022-10-25 | Arthrosurface Incorporated | Humeral and glenoid articular surface implant systems and methods |
CN118043010A (zh) * | 2021-08-03 | 2024-05-14 | 卡尔蒂希尔(2009)公司 | 促进包括大病损和高危群体在内骨软骨细胞和组织生长的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004520855A (ja) | 2000-03-14 | 2004-07-15 | シモン,ティモシー | 軟骨修復プラグ |
WO2013171736A1 (en) | 2012-05-17 | 2013-11-21 | Cartiheal(2009) Ltd | Biomatrix hydrogels and methods of use thereof |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378152A (en) * | 1992-05-01 | 1995-01-03 | Dental Marketing Specialists, Inc. | Method and apparatus for installation of dental implant |
US5642996A (en) * | 1993-10-20 | 1997-07-01 | Nikon Corporation | Endosseous implant |
US5490852A (en) | 1994-02-16 | 1996-02-13 | Azer; Samir N. | Orthopedic awl |
PT1504732E (pt) * | 1995-03-27 | 2007-08-30 | Warsaw Orthopedic Inc | Implantes de fusão vertebral e instrumentos para a sua inserção e revisão. |
EP1818025A3 (en) * | 1996-02-19 | 2007-12-05 | Warsaw Orthopedic, Inc. | Spinal fusion implants and tools for insertion and revision |
US5976147A (en) * | 1997-07-11 | 1999-11-02 | Johnson & Johnson Professional, Inc | Modular instrumentation for bone preparation and implant trial reduction of orthopedic implants |
US6099531A (en) * | 1998-08-20 | 2000-08-08 | Bonutti; Peter M. | Changing relationship between bones |
CA2442855A1 (en) * | 2001-04-12 | 2002-10-24 | Therics, Inc. | Method and apparatus for engineered regenerative biostructures |
US6761723B2 (en) | 2002-01-14 | 2004-07-13 | Dynamic Spine, Inc. | Apparatus and method for performing spinal surgery |
US7166133B2 (en) * | 2002-06-13 | 2007-01-23 | Kensey Nash Corporation | Devices and methods for treating defects in the tissue of a living being |
US7323011B2 (en) * | 2002-10-18 | 2008-01-29 | Musculoskeletal Transplant Foundation | Cortical and cancellous allograft cervical fusion block |
EP1778107A4 (en) * | 2003-12-31 | 2010-01-13 | Charles D Ray | TRUNCONIC BONE MELTING CAGES OR BLOCKS, METHOD AND MEANS FOR IMPLANTING |
US7837713B2 (en) * | 2004-11-22 | 2010-11-23 | Minsurg International, Inc. | Methods and surgical kits for minimally-invasive facet joint fusion |
US7901458B2 (en) * | 2005-12-16 | 2011-03-08 | Warsaw Orthopedic, Inc. | Intervertebral spacer and insertion tool |
US20070276506A1 (en) * | 2006-05-25 | 2007-11-29 | Biomet Manufacturing Corp. | Demineralized osteochondral plug |
US7758643B2 (en) | 2007-02-26 | 2010-07-20 | Biomet Sports Medicine, Llc | Stable cartilage defect repair plug |
US20090024174A1 (en) * | 2007-07-17 | 2009-01-22 | Stark John G | Bone screws and particular applications to sacroiliac joint fusion |
US8808725B2 (en) * | 2008-11-20 | 2014-08-19 | Cartiheal (2009) Ltd. | Solid forms for tissue repair |
KR20130038238A (ko) | 2010-03-19 | 2013-04-17 | 씨피엘 홀딩스 피티와이 엘티디 | 드릴 비트 |
KR101192662B1 (ko) | 2011-03-22 | 2012-10-19 | 주식회사 이노바이오써지 | 임플란트 시술용 드릴 |
EP2928390B1 (en) | 2012-12-10 | 2019-01-30 | The Curators of the University of Missouri | System and apparatus for grafting tissue |
KR102248576B1 (ko) | 2013-02-13 | 2021-05-06 | 카티힐 (2009) 엘티디. | 세포 및 조직 성장을 촉진하기 위한 고체 기질 |
US20160346091A1 (en) | 2013-04-30 | 2016-12-01 | Universiti Malaya | A method for manufacturing a customized implant |
WO2016178226A1 (en) | 2015-05-06 | 2016-11-10 | Cartiheal (2009) Ltd | Optimized solid substrates, tools for use with same and uses thereof for promoting cell and tissue growth |
WO2019135216A1 (en) | 2018-01-02 | 2019-07-11 | Cartiheal (2009) Ltd. | Implantation tool and protocol for optimized solid substrates promoting cell and tissue growth |
-
2016
- 2016-05-04 WO PCT/IL2016/050469 patent/WO2016178226A1/en active Application Filing
- 2016-05-04 KR KR1020177034870A patent/KR20180003587A/ko active IP Right Grant
- 2016-05-04 JP JP2017554568A patent/JP7143079B2/ja active Active
- 2016-05-04 CA CA2973549A patent/CA2973549A1/en active Pending
- 2016-05-04 AU AU2016259201A patent/AU2016259201B2/en active Active
- 2016-05-04 US US15/569,000 patent/US11007304B2/en active Active
-
2017
- 2017-07-25 ZA ZA2017/05050A patent/ZA201705050B/en unknown
- 2017-11-05 IL IL255447A patent/IL255447B2/en unknown
-
2020
- 2020-12-10 AU AU2020286266A patent/AU2020286266B2/en active Active
- 2020-12-17 AU AU2020289800A patent/AU2020289800A1/en not_active Withdrawn
-
2021
- 2021-03-22 JP JP2021047410A patent/JP2021112572A/ja active Pending
- 2021-04-16 US US17/232,279 patent/US12070529B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004520855A (ja) | 2000-03-14 | 2004-07-15 | シモン,ティモシー | 軟骨修復プラグ |
WO2013171736A1 (en) | 2012-05-17 | 2013-11-21 | Cartiheal(2009) Ltd | Biomatrix hydrogels and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
US20210244853A1 (en) | 2021-08-12 |
AU2020289800A1 (en) | 2021-01-28 |
IL255447B1 (en) | 2023-03-01 |
US11007304B2 (en) | 2021-05-18 |
AU2016259201B2 (en) | 2020-09-24 |
AU2020286266B2 (en) | 2022-05-12 |
ZA201705050B (en) | 2024-01-31 |
WO2016178226A1 (en) | 2016-11-10 |
AU2016259201A1 (en) | 2017-07-13 |
AU2016259201A9 (en) | 2019-08-01 |
US20180154041A1 (en) | 2018-06-07 |
KR20180003587A (ko) | 2018-01-09 |
IL255447A0 (en) | 2017-12-31 |
CA2973549A1 (en) | 2016-11-10 |
JP2021112572A (ja) | 2021-08-05 |
AU2020286266A1 (en) | 2021-01-21 |
US12070529B2 (en) | 2024-08-27 |
IL255447B2 (en) | 2023-07-01 |
WO2016178226A9 (en) | 2018-01-25 |
JP2018520712A (ja) | 2018-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7143079B2 (ja) | 最適化された固体基材、それとともに使用するためのツールならびに細胞及び組織の成長を促進するためのその使用 | |
US7488348B2 (en) | Cartilage allograft plug | |
US7837740B2 (en) | Two piece cancellous construct for cartilage repair | |
JP5795577B2 (ja) | 組織修復のための固形形態 | |
US7427293B2 (en) | Osteochondral plug graft, kit and method | |
US8795361B2 (en) | Osteochondral plug graft, kit and method | |
KR102248576B1 (ko) | 세포 및 조직 성장을 촉진하기 위한 고체 기질 | |
US20050222687A1 (en) | Cartilage implant assembly and method for implantation | |
US20050064042A1 (en) | Cartilage implant plug with fibrin glue and method for implantation | |
US20110196508A1 (en) | Cartilage repair mixture containing allograft chondrocytes | |
US20200368027A1 (en) | Implantation Tool and Protocol for Optimized Solid Substrates Promoting Cell and Tissue Growth | |
EP3291749B1 (en) | Tools for use with optimized solid substrates | |
CN118043010A (zh) | 促进包括大病损和高危群体在内骨软骨细胞和组织生长的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190426 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190426 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200227 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200310 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200610 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20201124 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20210322 |
|
C116 | Written invitation by the chief administrative judge to file amendments |
Free format text: JAPANESE INTERMEDIATE CODE: C116 Effective date: 20210406 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20210406 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20210914 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20211116 |
|
C13 | Notice of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: C13 Effective date: 20211214 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220310 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20220412 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220614 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20220628 |
|
C23 | Notice of termination of proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C23 Effective date: 20220726 |
|
C03 | Trial/appeal decision taken |
Free format text: JAPANESE INTERMEDIATE CODE: C03 Effective date: 20220830 |
|
C30A | Notification sent |
Free format text: JAPANESE INTERMEDIATE CODE: C3012 Effective date: 20220830 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220914 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7143079 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |